Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
c-KIT inhibitor
DRUG CLASS:
c-KIT inhibitor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
YD312 (21)
ripretinib (11)
MLN518 (8)
SU5614 (6)
ABT-869 (2)
AG-1296 (1)
OSI-930 (1)
MP470 (1)
PLX9486 (1)
E7050 (1)
GSK6042981 (1)
CDX-0158 (0)
M4205 (0)
NB003 (0)
NMS-088 (0)
JSP191 (0)
AER-901 (0)
TSU-68 (0)
BAY 57- 9352 (0)
PTK787 (0)
YD312 (21)
ripretinib (11)
MLN518 (8)
SU5614 (6)
ABT-869 (2)
AG-1296 (1)
OSI-930 (1)
MP470 (1)
PLX9486 (1)
E7050 (1)
GSK6042981 (1)
CDX-0158 (0)
M4205 (0)
NB003 (0)
NMS-088 (0)
JSP191 (0)
AER-901 (0)
TSU-68 (0)
BAY 57- 9352 (0)
PTK787 (0)
›
Associations
(54)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Gastrointestinal Stromal Tumor
No biomarker
Gastrointestinal Stromal Tumor
ripretinib
Sensitive: A1 - Approval
ripretinib
Sensitive
:
A1
ripretinib
Sensitive: A1 - Approval
ripretinib
Sensitive
:
A1
No biomarker
Chronic Myeloid Leukemia
No biomarker
Chronic Myeloid Leukemia
YD312
Sensitive: A2 - Guideline
YD312
Sensitive
:
A2
YD312
Sensitive: A2 - Guideline
YD312
Sensitive
:
A2
No biomarker
Chordoma
No biomarker
Chordoma
YD312
Sensitive: A2 - Guideline
YD312
Sensitive
:
A2
YD312
Sensitive: A2 - Guideline
YD312
Sensitive
:
A2
No biomarker
Kaposi Sarcoma
No biomarker
Kaposi Sarcoma
YD312
Sensitive: A2 - Guideline
YD312
Sensitive
:
A2
YD312
Sensitive: A2 - Guideline
YD312
Sensitive
:
A2
SDHB deletion
Gastrointestinal Stromal Tumor
SDHB deletion
Gastrointestinal Stromal Tumor
binimetinib + YD312
Sensitive: A2 - Guideline
binimetinib + YD312
Sensitive
:
A2
binimetinib + YD312
Sensitive: A2 - Guideline
binimetinib + YD312
Sensitive
:
A2
PDGFRA exon 18 mutation
Gastrointestinal Stromal Tumor
PDGFRA exon 18 mutation
Gastrointestinal Stromal Tumor
ripretinib
Sensitive: A2 - Guideline
ripretinib
Sensitive
:
A2
ripretinib
Sensitive: A2 - Guideline
ripretinib
Sensitive
:
A2
KIT mutation
Gastrointestinal Stromal Tumor
KIT mutation
Gastrointestinal Stromal Tumor
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
PDGFRA mutation
Gastrointestinal Stromal Tumor
PDGFRA mutation
Gastrointestinal Stromal Tumor
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
KIT exon 17 mutation
Gastrointestinal Stromal Tumor
KIT exon 17 mutation
Gastrointestinal Stromal Tumor
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
KIT exon 13 mutation
Gastrointestinal Stromal Tumor
KIT exon 13 mutation
Gastrointestinal Stromal Tumor
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
KIT exon 9 mutation
Gastrointestinal Stromal Tumor
KIT exon 9 mutation
Gastrointestinal Stromal Tumor
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
KIT exon 11 mutation
Gastrointestinal Stromal Tumor
KIT exon 11 mutation
Gastrointestinal Stromal Tumor
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.